185 related articles for article (PubMed ID: 36978144)
1. The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLE.
Nie Y; Sun B; He X; Zheng M; Wu D; Yang Y; Zhang L; Bai W; Jiang N; Qiao L; Huang C; Zhou S; Zhou J; Peng L; Niu J; Li M; Zhao Y; Zeng X; Wang L; Zhang W
Arthritis Res Ther; 2023 Mar; 25(1):50. PubMed ID: 36978144
[TBL] [Abstract][Full Text] [Related]
2. [Neuropsychiatric manifestations in systemic lupus erythematosus and the treatment of intrathecal methotrexate plus dexamethasone].
Zhou HQ; Leng XM; Zhang FC
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):771-4. PubMed ID: 16681954
[TBL] [Abstract][Full Text] [Related]
3. Impact analysis of autoantibody level and NR2 antibody level in neuropsychiatric SLE treated by methylprednisolone combined with MTX and DXM intrathecal injection.
Wang J; Zhao Y; Zhang J; Lei H; Zhu G; Fu B
Cell Biochem Biophys; 2014 Nov; 70(2):1005-9. PubMed ID: 24845150
[TBL] [Abstract][Full Text] [Related]
4. [Clinical manifestations, laboratory test, treatment and outcome of neuropsychiatric involvement in pediatric systemic lupus erythematosus patients].
Wu XY; Song HM; Zeng XF; He YY; Wang W; Li F; Guo YZ; Wei M
Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):286-90. PubMed ID: 19555568
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus.
Jiang M; Shi X; Gao X; Niu J; Hu X; Zhao L; Zhang X
Arthritis Res Ther; 2019 Aug; 21(1):189. PubMed ID: 31426834
[TBL] [Abstract][Full Text] [Related]
6. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.
Shimizu Y; Yasuda S; Kako Y; Nakagawa S; Kanda M; Hisada R; Ohmura K; Shimamura S; Shida H; Fujieda Y; Kato M; Oku K; Bohgaki T; Horita T; Kusumi I; Atsumi T
Autoimmun Rev; 2016 Aug; 15(8):786-94. PubMed ID: 27016478
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients.
Zhou HQ; Zhang FC; Tian XP; Leng XM; Lu JJ; Zhao Y; Tang FL; Zhang X; Zeng XF; Zhang ZL; Zhang W; Dong Y
Lupus; 2008 Feb; 17(2):93-9. PubMed ID: 18250131
[TBL] [Abstract][Full Text] [Related]
8. [Neuropsychiatric manifestations in patients with systemic lupus erythematosus: about 108 cases in Cameroon].
Yacouba MN; Francine SB; Francois BNJ; Paul EO; Caroline K; Daniel GM; Jacques D; Madeleine NS
Pan Afr Med J; 2022; 42():241. PubMed ID: 36303819
[TBL] [Abstract][Full Text] [Related]
9. Differences between central nervous system infection and neuropsychiatric systemic lupus erythematosus in patients with systemic lupus erythematosus.
Fang H; Lan L; Qu Y; Zhang Q; Lv J
J Int Med Res; 2018 Jan; 46(1):485-491. PubMed ID: 28823196
[TBL] [Abstract][Full Text] [Related]
10. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
11. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
Hirohata S; Arinuma Y; Yanagida T; Yoshio T
Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India.
Pradhan V; Patwardhan M; Rajadhyaksha A; Dhawale N; Ghosh K
Rheumatol Int; 2015 Mar; 35(3):541-5. PubMed ID: 25119833
[TBL] [Abstract][Full Text] [Related]
14. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
15. Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score.
Labouret M; Trebossen V; Ntorkou A; Bartoli S; Aubart M; Auvin S; Bader-Meunier B; Baudouin V; Corseri O; Dingulu G; Ducrocq C; Dumaine C; Elmaleh M; Fabien N; Faye A; Hau I; Hentgen V; Kwon T; Meinzer U; Ouldali N; Parmentier C; Pouletty M; Renaldo F; Savioz I; Benoist JF; Le Roux E; Ellul P; Melki I
Lupus; 2024 Apr; 33(4):328-339. PubMed ID: 38315109
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric lupus in Malaysian children: clinical characteristics, imaging features and 12-month outcomes.
Lim SC; Md-Yusof YL; Johari B; Abdul-Kadir RF; Tang SP
Turk J Pediatr; 2021; 63(5):743-751. PubMed ID: 34738356
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study.
Gao Y; Lau EY; Wan JH; Lau CS; Mok MY
Lupus; 2016 May; 25(6):637-44. PubMed ID: 26700182
[TBL] [Abstract][Full Text] [Related]
18. Predictors of clinical outcomes in patients with neuropsychiatric systemic lupus erythematosus.
Ichinose K; Arima K; Umeda M; Fukui S; Nishino A; Nakashima Y; Suzuki T; Horai Y; Koga T; Kawashiri SY; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Sato S; Origuchi T; Kawakami A
Cytokine; 2016 Mar; 79():31-7. PubMed ID: 26745468
[TBL] [Abstract][Full Text] [Related]
19. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
George-Chandy A; Trysberg E; Eriksson K
Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
[TBL] [Abstract][Full Text] [Related]
20. Diminished white matter integrity in patients with systemic lupus erythematosus.
Schmidt-Wilcke T; Cagnoli P; Wang P; Schultz T; Lotz A; Mccune WJ; Sundgren PC
Neuroimage Clin; 2014; 5():291-7. PubMed ID: 25161895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
